Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2397
-0.0053-2.16%
Post-market: 0.24280.0031+1.29%16:18 EDT
Volume:557.19K
Turnover:133.82K
Market Cap:63.53M
PE:-0.82
High:0.2471
Open:0.2400
Low:0.2371
Close:0.2450
Loading ...

Adaptimmune Therapeutics PLC expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
10 May

European Equities Traded in the US as American Depositary Receipts Marginally Higher in Monday Trading

MT Newswires Live
·
05 May

European Equities Traded in the US as American Depositary Receipts Jump in Friday Trading

MT Newswires Live
·
02 May

European Equities Traded in the US as American Depositary Receipts Drop Sharply in Wednesday Trading

MT Newswires Live
·
30 Apr

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
22 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
21 Apr

Adaptimmune Therapeutics Plc - CFO Gavin Wood's Termination Date Extended to August 31, 2025 - SEC Filing

THOMSON REUTERS
·
15 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
14 Apr

Adaptimmune downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
12 Apr

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading

MT Newswires Live
·
11 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
08 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Adaptimmune Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
01 Apr

Adaptimmune Therapeutics Plc : H.c. Wainwright Cuts Target Price to $3 From $3.5

THOMSON REUTERS
·
01 Apr

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

MT Newswires Live
·
28 Mar

Barclays Remains a Sell on Adaptimmune Therapeutics (ADAP)

TIPRANKS
·
27 Mar

Adaptimmune Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
26 Mar

Adaptimmune Therapeutics Plc : Guggenheim Cuts Target Price to $1.75 From $3

THOMSON REUTERS
·
26 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
25 Mar

Adaptimmune Therapeutics (ADAP) Gets a Buy from Scotiabank

TIPRANKS
·
25 Mar